{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:17:22Z","timestamp":1767845842829,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1083105C, 1087314C, 1073108C, 1063102B, 1067328D, 1067314C"],"award-info":[{"award-number":["TCVGH-1083105C, 1087314C, 1073108C, 1063102B, 1067328D, 1067314C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00380-020-01733-7","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T06:03:08Z","timestamp":1609653788000},"page":"615-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Subjects with coronary artery disease and reduced ejection fraction have longer (GT)n repeats in the heme-oxygenase 1 gene promoter"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-9614","authenticated-orcid":false,"given":"Kae-Woei","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jane","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Lieng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Pey","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Te","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Sing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne H.-H.","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"1733_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"1733_CR2","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation 136:e137\u2013e161","journal-title":"Circulation"},{"key":"1733_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jacc.2008.06.019","volume":"52","author":"NK Idriss","year":"2008","unstructured":"Idriss NK, Blann AD, Lip GY (2008) Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 52:971\u2013978","journal-title":"J Am Coll Cardiol"},{"key":"1733_CR4","first-page":"52","volume":"28","author":"RF Furchgott","year":"1991","unstructured":"Furchgott RF, Jothianandan D (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52\u201361","journal-title":"Blood Vessels"},{"key":"1733_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCULATIONAHA.107.698316","volume":"117","author":"J Dulak","year":"2008","unstructured":"Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117:231\u2013241","journal-title":"Circulation"},{"key":"1733_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1726-4901(09)70035-8","volume":"72","author":"CC Lin","year":"2009","unstructured":"Lin CC, Yang WC (2009) Prognostic factors influencing the patency of hemodialysis vascular access: literature review and novel therapeutic modality by far infrared therapy. J Chin Med Assoc 72:109\u2013116","journal-title":"J Chin Med Assoc"},{"key":"1733_CR7","first-page":"150","volume":"1","author":"ML Wu","year":"2011","unstructured":"Wu ML, Ho YC, Lin CY, Yet SF (2011) Heme oxygenase-1 in inflammation and cardiovascular disease. Am J Cardiovasc Dis 1:150\u2013158","journal-title":"Am J Cardiovasc Dis"},{"key":"1733_CR8","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1089\/ars.2010.3726","volume":"15","author":"ML Wu","year":"2011","unstructured":"Wu ML, Ho YC, Yet SF (2011) A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal 15:1835\u20131846","journal-title":"Antioxid Redox Signal"},{"key":"1733_CR9","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1161\/CIRCULATIONAHA.109.905471","volume":"121","author":"G Wang","year":"2010","unstructured":"Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, Prabhu SD (2010) Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121:1912\u20131925","journal-title":"Circulation"},{"key":"1733_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/hh1401.093314","volume":"89","author":"SF Yet","year":"2001","unstructured":"Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89:168\u2013173","journal-title":"Circ Res"},{"key":"1733_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2014.03.026","volume":"734","author":"JF Ndisang","year":"2014","unstructured":"Ndisang JF, Chibbar R, Lane N (2014) Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension. Eur J Pharmacol 734:23\u201334","journal-title":"Eur J Pharmacol"},{"key":"1733_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-002-0769-4","volume":"111","author":"YH Chen","year":"2002","unstructured":"Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:1\u20138","journal-title":"Hum Genet"},{"key":"1733_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/152660280100800501","volume":"8","author":"M Exner","year":"2001","unstructured":"Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O (2001) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8:433\u2013440","journal-title":"J Endovasc Ther"},{"key":"1733_CR14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/ATVBAHA.110.207316","volume":"30","author":"H Taha","year":"2010","unstructured":"Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, Jozkowicz A (2010) Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30:1634\u20131641","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1733_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/aje\/kwu024","volume":"179","author":"H Qiao","year":"2014","unstructured":"Qiao H, Sai X, Gai L, Huang G, Chen X, Tu X, Ding Z (2014) Association between heme oxygenase 1 gene promoter polymorphisms and susceptibility to coronary artery disease: a HuGE review and meta-analysis. Am J Epidemiol 179:1039\u20131048","journal-title":"Am J Epidemiol"},{"key":"1733_CR16","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/01.ATV.0000033515.96747.6F","volume":"22","author":"H Kaneda","year":"2002","unstructured":"Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22:1680\u20131685","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1733_CR17","doi-asserted-by":"publisher","first-page":"83437","DOI":"10.18632\/oncotarget.13118","volume":"7","author":"MM Zhang","year":"2016","unstructured":"Zhang MM, Zheng YY, Gao Y, Zhang JZ, Liu F, Yang YN, Li XM, Ma YT, Xie X (2016) Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis. Oncotarget 7:83437\u201383450","journal-title":"Oncotarget"},{"key":"1733_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cjca.2015.06.006","volume":"32","author":"KE Daenen","year":"2016","unstructured":"Daenen KE, Martens P, Bammens B (2016) Association of HO-1 (GT)n promoter polymorphism and cardiovascular disease: a reanalysis of the literature. Can J Cardiol 32:160\u2013168","journal-title":"Can J Cardiol"},{"key":"1733_CR19","doi-asserted-by":"crossref","unstructured":"Bai CH, Chen JR, Chiu HC, Chou CC, Chau LY, Pan WH Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. J Biomed Sci 17:12.","DOI":"10.1186\/1423-0127-17-12"},{"key":"1733_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/aje\/kwq162","volume":"172","author":"W Bao","year":"2010","unstructured":"Bao W, Song F, Li X, Rong S, Yang W, Wang D, Xu J, Fu J, Zhao Y, Liu L (2010) Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 172:631\u2013636","journal-title":"Am J Epidemiol"},{"key":"1733_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ehj.2003.10.009","volume":"25","author":"YH Chen","year":"2004","unstructured":"Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, Lin SJ (2004) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 25:39\u201347","journal-title":"Eur Heart J"},{"key":"1733_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/ATVBAHA.114.304729","volume":"35","author":"R Pechlaner","year":"2015","unstructured":"Pechlaner R, Willeit P, Summerer M, Santer P, Egger G, Kronenberg F, Demetz E, Weiss G, Tsimikas S, Witztum JL, Willeit K, Iglseder B, Paulweber B, Kedenko L, Haun M, Meisinger C, Gieger C, Muller-Nurasyid M, Peters A, Willeit J, Kiechl S (2015) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arterioscler Thromb Vasc Biol 35:229\u2013236","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1733_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jcma.2013.03.005","volume":"76","author":"KW Liang","year":"2013","unstructured":"Liang KW, Sheu WH, Lee WL, Lee IT, Lin SY, Ting CT, Lee WJ (2013) Shorter GT repeats in the heme oxygenase-1 gene promoter are associated with a lower severity score in coronary artery disease. J Chin Med Assoc 76:312\u2013318","journal-title":"J Chin Med Assoc"},{"key":"1733_CR24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00246-015-1146-0","volume":"36","author":"S Sayed","year":"2015","unstructured":"Sayed S, Idriss NK, Blann A, Sayyed HG, Raafat DM, Fouad D, Tawfeek MS (2015) The number of GT(n) repeats in the hemeoxygenase-1 gene promoter is increased in pediatric heart failure but is unrelated to renal, antioxidant and anti-inflammatory markers. Pediatr Cardiol 36:1204\u20131211","journal-title":"Pediatr Cardiol"},{"key":"1733_CR25","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219\u2013227","journal-title":"EuroIntervention"},{"key":"1733_CR26","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1172\/JCI6163","volume":"103","author":"SF Yet","year":"1999","unstructured":"Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103:R23-29","journal-title":"J Clin Invest"},{"key":"1733_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.2337\/diabetes.54.3.778","volume":"54","author":"X Liu","year":"2005","unstructured":"Liu X, Wei J, Peng DH, Layne MD, Yet SF (2005) Absence of heme oxygenase-1 exacerbates myocardial ischemia\/reperfusion injury in diabetic mice. Diabetes 54:778\u2013784","journal-title":"Diabetes"},{"key":"1733_CR28","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1093\/eurheartj\/ehv544","volume":"36","author":"P Wenzel","year":"2015","unstructured":"Wenzel P, Rossmann H, Muller C, Kossmann S, Oelze M, Schulz A, Arnold N, Simsek C, Lagrange J, Klemz R, Schonfelder T, Brandt M, Karbach SH, Knorr M, Finger S, Neukirch C, Hauser F, Beutel ME, Kroller-Schon S, Schulz E, Schnabel RB, Lackner K, Wild PS, Zeller T, Daiber A, Blankenberg S, Munzel T (2015) Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur Heart J 36:3437\u20133446","journal-title":"Eur Heart J"},{"key":"1733_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/ATVBAHA.107.160085","volume":"28","author":"CC Lin","year":"2008","unstructured":"Lin CC, Liu XM, Peyton K, Wang H, Yang WC, Lin SJ, Durante W (2008) Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 28:739\u2013745","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01733-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-020-01733-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01733-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T03:28:40Z","timestamp":1617938920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-020-01733-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01733-7","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}